Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes

Inflammopharmacology

Volumn 16, Issue 3, 2008, Pages 126-132

  Graham, G G ^a,c   Whitehouse, M W ^b   Bushell, G R ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOGLUCOSE; AUROTHIOMALATE; DRUG METABOLITE; GOLD COMPLEX; GOLD CYANIDE; HYDROGEN CYANIDE; HYPOCHLORITE; MYELOPEROXIDASE; SODIUM AUROTHIOSULFATE; THIOCYANATE;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ATHEROSCLEROSIS; CHEMISTRY; DRUG METABOLISM; DRUG SYNTHESIS; HISTORY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; CYANATES; FEMALE; GOLD; GOLD SODIUM THIOMALATE; RATS; RATS, WISTAR;

EID: 46449108733     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-0020-y     Document Type: Review

References (34)

1. Canumalla, A. J., Al-Zamil, N., Phillips, M. et al. (2001). Redox and ligand exchange of potential gold(I) and gold(III)-cyanide metabolites under biomimetic conditions, J. Inorg. Biochem. 85, 67-76.
2. Daugherty, A., Dunn, J. L., Rateri, D. L. and Heinecke, J. W. (1994). Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions, J. Clin. Invest. 94, 437-444.
3. Eisler, R. (2004). Biogeochemical, health and ecotoxicological perspectives on gold and gold mining. Boca Raton, CRC Press. pp. 189-195.
4. Elder, R. C., Jones, W. B., Zhao, Z. et al. (1994). Myochrysine solution structure and reactivity, Metal Based Drugs 1, 363-374.
5. Elder, R. C., Zhao, Z., Zhang, Y. et al. (1993). Dicyano gold(I) is a common human metabolite of different gold drugs, J. Rheumatol. 20, 268-272.
6. Gadd, S. J., Whitehouse, M. W., Vernon-Roberts, B. (1992). Ambivalent effects of aurocyanide, a putative active metabolite of anti-arthritic gold drugs, on human and rats PMN leucocytes, Inflammopharmacol. 1, 305-314.
7. 13C NMR and electronic absorption spectroscopic studies of the interaction of cyanide and aurothiomalate, J. Inorg. Biochem. 25, 163-173.
8. Graham, G. G., Champion, G. D. and Ziegler, J.B. (1994) The cellular metabolism and effects of gold complexes, Metal Based Drugs 1, 395-404.
9. Graham, G. G. and Dale, M. M. (1990). The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. II. Evidence for the formation and biological activity of aurocyanide, Biochem. Pharmacol. 39, 1697-1702.
10. Graham, G. G., Haavisto, T. M., Jones, H. M. and Champion, G. D. (1984). The effect of cyanide on the uptake of gold by red blood cells, Biochem. Pharmacol. 33, 1257-1262.
11. Graham, G. G., Haavisto, T. M., McNaught, P. J. et al. (1982). The effect of smoking on the distribution of gold in blood, J. Rheumatol. 9, 527-31.
12. Graham, G. G. and Kettle, A. J. (1998). The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase. Biochem. Pharmacol. 56, 307-312.
13. Koch, R. (1890). An address on biological research, Brit. Med. J. 2, 380-383.
14. Kumeda, Y., Inaba, M., Goto, H., Nagata, M., Henmi, Y., Furumitsu, Y. et al., (2002). Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis, Arthritis Rheum. 46, 1489-1497.
15. Laist, J. W. (1954). Copper, silver and gold in Comprehensive inorganic chemistry (eds. Sneed, M. C., Maynard, J. L., Brasteed, R. C.) New York, van Nostrand Co. Vol.II, pp. 195-206.
16. Lehtinen K. and Isomaki, H. (1991). Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis, J. Rheumatol. 18, 524-529.
17. Miller, B. and Menezes-Affonso, S. (1976). Conductivity and other transport parameters in ammonium citrate gold baths, J. Electrochem. Soc. 123, 1006-1010.
18. Pesek, J. J. and Mason, W. R. (1979). Carbon-13 magnetic resonance spectra of diamagnetic complexes, Inorg. Chem. 18, 924-928.
19. Raubenheimer, H. G. and Cronje, S. (1999). Gold cyano compounds, in: Gold: Progress in chemistry, biochemistry and technology, H. Schmidbaur (Ed.), pp. 600-604. John Wiley, Chichester UK.
20. Roos, I. A., Fairlie, D. P., Whitehouse, M. W. (1980). A peculiar toxicity manifested by platinum (II) ammines in rats: gastric distension after i. p. administration, Chem. Biol. Interactions. 35, 111-117.
21. Schuhmann, D., Kubicka-Muranyi, M., Mirtschewa, J. et al. (1990). Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitises mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation, J. Immunol. 145, 2132-2139.
22. -) and an engineered cysteine (T338C) blocks the pore, Biophys. J. 91, 1737-1748.
23. Sharpe, A. G. (1976). Chemistry of cyanocompounds of the transition metals. pp. 265-283 (Chapter X on Cu, Ag, Au). Academic Press, London.
24. Shaw, C. F. (1999). The biochemistry of gold, in: Gold: Progress in Chemistry, Biochemistry and Technology, H. Schmidbaur (Ed.), pp. 259-308. John Wiley, Chichester UK.
25. -] in the formation of gold metabolites, Metal Based Drugs 1, 351-362.
26. Sherer, Y., Shoenfeld, Y. (2006). Mechanisms of disease: atherosclerosis in autoimmune diseases. Nature Clin. Prac, Rheumatol. 2, 99-106.
27. Smith, S. S., Steinle, E. D., Myerhoff, M. E. and Dawson, D. C. (1999). Cystic transmembrane conductance regulator. Physical basis for lyotropic anion selectivity patterns, J. Gen. Physiol. 114, 799-818.
28. -] to human serum albumin, J. Biol. Inorg. Chem. 11, 559-570.
29. Tepperman, K., Zhang, Y., Roy, P. W. et al. (1994). Transport of the dicyanogold(I) anion, Metal Based Drugs 1, 433-443.
30. Van Doornum, S., McColl, G., Wicks, I. P. (2002). Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 46, 862-873.
31. Verwilghen, J., Kingsley, G. H. Gambling, L. and Panayi, G. S. (1992). Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold, Arthritis Rheum. 35, 1413-1418.
32. Whitehouse, M. W. and Butters, D. E. (2003). Combination anti-inflammatory therapy: synergism in rats of NSAIDs/corticosteroids with some herbal/animal products, Inflammopharmacol. 11, 453-464.
33. Wright, I. H. and Vesey, C. J. (1986). Acute poisoning with gold cyanide, Anaesthesia. 41, 936-939.
34. Wu, M. L., Thsai, W. J., Ger, J., Deng, F., Tsay, S. H., Yang, M. H. (2001). Cholestatic hepatitis caused by acute gold potassium cyanide poisoning, J. Toxicol. Clin. Toxicol. 39, 739-743.